miR-149-3p targeting TMPRSS4 regulates the sensitivity to cisplatin to inhibit the progression of lung cancer. Biomol Biomed [Internet]. 2024 Dec. 11 [cited 2025 Apr. 16];25(1):165–176. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11163